DK1149840T3 - Drospirenon (6b, 7b, 15b, 16b-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) med mindre end 0,2% forurening - Google Patents

Drospirenon (6b, 7b, 15b, 16b-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) med mindre end 0,2% forurening

Info

Publication number
DK1149840T3
DK1149840T3 DK01250277T DK01250277T DK1149840T3 DK 1149840 T3 DK1149840 T3 DK 1149840T3 DK 01250277 T DK01250277 T DK 01250277T DK 01250277 T DK01250277 T DK 01250277T DK 1149840 T3 DK1149840 T3 DK 1149840T3
Authority
DK
Denmark
Prior art keywords
17alpha
dimethylene
carbolactone
oxo
pregn
Prior art date
Application number
DK01250277T
Other languages
English (en)
Other versions
DK1149840T5 (da
DK1149840T4 (da
Inventor
Klaus Nickisch
Joerg-Thorsten Mohr
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7803224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1149840(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of DK1149840T3 publication Critical patent/DK1149840T3/da
Application granted granted Critical
Publication of DK1149840T4 publication Critical patent/DK1149840T4/da
Publication of DK1149840T5 publication Critical patent/DK1149840T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Fats And Perfumes (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK01250277.9T 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af drospirenon DK1149840T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19633685A DE19633685C1 (de) 1996-08-12 1996-08-12 Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
PCT/EP1997/004342 WO1998006738A1 (de) 1996-08-12 1997-08-11 Verfahren zur herstellung von drospirenon und zwischenprodukten davon

Publications (3)

Publication Number Publication Date
DK1149840T3 true DK1149840T3 (da) 2009-04-27
DK1149840T4 DK1149840T4 (da) 2013-07-01
DK1149840T5 DK1149840T5 (da) 2013-09-30

Family

ID=7803224

Family Applications (4)

Application Number Title Priority Date Filing Date
DK09100011.7T DK2168974T3 (da) 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af drospirenon (6SS, 7ß, 15SS, 16ss-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolactoner, DRSP)
DK97937562T DK0918791T3 (da) 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af drospirenon og mellemprodukter deraf
DK01250278.7T DK1149841T3 (da) 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af 6beta, 7beta; 15beta, 16beta-dimethylen-5beta-hydroxy-3-oxo-17alfa-androstan-21,17-carbonlacton
DK01250277.9T DK1149840T5 (da) 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af drospirenon

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK09100011.7T DK2168974T3 (da) 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af drospirenon (6SS, 7ß, 15SS, 16ss-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolactoner, DRSP)
DK97937562T DK0918791T3 (da) 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af drospirenon og mellemprodukter deraf
DK01250278.7T DK1149841T3 (da) 1996-08-12 1997-08-11 Fremgangsmåde til fremstilling af 6beta, 7beta; 15beta, 16beta-dimethylen-5beta-hydroxy-3-oxo-17alfa-androstan-21,17-carbonlacton

Country Status (27)

Country Link
US (2) US6121465A (da)
EP (4) EP2168974B1 (da)
JP (1) JP3333524B2 (da)
KR (1) KR100473297B1 (da)
CN (1) CN1158300C (da)
AT (3) ATE446966T1 (da)
AU (1) AU729149B2 (da)
BG (1) BG62776B1 (da)
BR (1) BR9711060A (da)
CA (1) CA2261137C (da)
CZ (1) CZ297255B6 (da)
DE (4) DE19633685C1 (da)
DK (4) DK2168974T3 (da)
EA (1) EA001947B1 (da)
ES (4) ES2320626T5 (da)
HK (1) HK1021190A1 (da)
HU (1) HU223106B1 (da)
IL (1) IL127963A (da)
IS (1) IS2100B (da)
NZ (1) NZ333697A (da)
PL (1) PL187474B1 (da)
PT (4) PT2168974E (da)
SI (3) SI1149840T2 (da)
SK (1) SK283546B6 (da)
TR (1) TR199900262T2 (da)
UA (1) UA55423C2 (da)
WO (1) WO1998006738A1 (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
PT1214076E (pt) 1999-08-31 2004-04-30 Schering Ag Combinacao farmaceutica de etinilestradiol e drospirenona para utilizacao como um contraceptivo
EP2305267A3 (en) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
SK287719B6 (en) * 2000-01-18 2011-07-06 Bayer Schering Pharma Ag Drospirenone for hormone replacement therapy
EP1406634A1 (en) 2001-07-13 2004-04-14 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
AU2003239162A1 (en) 2002-04-26 2003-11-10 Schering Ag Treatment of hypertension in women receiving hormone replacement therapy
US7786101B2 (en) * 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
CL2004000574A1 (es) * 2003-03-21 2005-02-11 Pharmacia Corp Sa Organizada B Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion.
ITMI20040367A1 (it) * 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
HUP0402465A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
DE102004058300B4 (de) * 2004-12-02 2016-09-15 Austriamicrosystems Ag Schaltungsanordnung zur Erzeugung eines komplexen Signals und Verwendung in einem Hochfrequenz-Sender oder -Empfänger
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
DE502005004948D1 (de) * 2005-07-21 2008-09-18 Bayer Schering Pharma Ag Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
US7319154B2 (en) 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
KR101410583B1 (ko) * 2005-07-21 2014-06-23 바이엘 파마 악티엔게젤샤프트 17-(3-히드록시프로필)-3,17-디히드록시안드로스탄의금속-무함유 산화에 의한3-옥소-프레근-4-엔-21,17-카르보락톤의 제조 방법
US20070255381A1 (en) 2006-04-27 2007-11-01 Peter Meyer Electrode pad packaging systems and methods
EP1902711A1 (en) * 2006-09-20 2008-03-26 KAIROSmed GmbH Oral modified release formulations containing Drospirenon and 8-Prenylnaringenin for use in Hormone Replacement Therapy (HRT)
WO2008137050A2 (en) 2007-05-01 2008-11-13 Sicor Inc. A process for preparing drospirenone and intermediate thereof
DE102007030596B3 (de) * 2007-06-28 2009-03-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung von 17-(3-Hydroxypropyl)-17-hydroxysteroiden
US7960368B2 (en) * 2008-03-05 2011-06-14 Everstra, Inc. Bismethylene-17A carbolactones and related uses
US8222237B2 (en) * 2008-11-25 2012-07-17 Evestra, Inc. Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
WO2010094623A1 (en) 2009-02-18 2010-08-26 Bayer Schering Pharma Aktiengesellschaft Formulation comprising drospirenone for subcutaneous or intramuscular administration
US20120114757A1 (en) 2009-02-18 2012-05-10 Bayer Pharma Aktiengesellschaft Particles comprising drospirenone encapsulated in a polymer
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
ES2432063T3 (es) * 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
DE102009031909B4 (de) 2009-07-01 2017-02-09 Heyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg Verfahren zur Herstellung von Drospirenon aus Prasteron
US8921346B2 (en) 2010-03-16 2014-12-30 Taizhou Taifa Pharmaceuticals Co., Ltd. Preparation method of drospirenone
CN101830959B (zh) * 2010-05-27 2012-07-18 杭州龙山化工有限公司 一种曲螺酮的合成方法
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
ES2419663T3 (es) 2010-08-03 2013-08-21 Newchem S.P.A. Métodos para la preparación de Drospirenona y productos intermedios de la misma
WO2012107513A1 (en) 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
ITMI20111383A1 (it) 2011-07-25 2013-01-26 Ind Chimica Srl Processo per la preparazione di drospirenone
CA2854215A1 (en) * 2011-11-04 2013-05-10 Bayer Pharma Aktiengesellschaft 18-methyl-6,7-methylene-3-oxo-17-pregn-4-ene-21,17.beta.-carbolactones, pharmaceutical preparations comprising said compounds and use thereof in the treatment of endometriosis
EP2597101A1 (en) 2011-11-22 2013-05-29 Industriale Chimica S.R.L. Process for the preparation of drospirenone
CA2856324C (en) 2011-11-22 2019-08-13 Industriale Chimica S.R.L. Process for the preparation of drospirenone
ES2651145T3 (es) 2013-02-20 2018-01-24 Industriale Chimica S.R.L. Proceso para la preparación de drospirenona
HUE032858T2 (en) 2013-04-12 2017-11-28 Ind Chimica Srl Method for producing drospirenone
MY187233A (en) 2015-06-23 2021-09-13 Laboratorios Leon Farma Sa Drospirenone-based contraceptive for a female patient affected with excess weight
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
CN113387993A (zh) * 2021-07-06 2021-09-14 江西百思康瑞药业有限公司 一种屈螺酮的合成方法
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception
WO2023152658A1 (en) 2022-02-10 2023-08-17 Lupin Limited Slow release drospirenone tablet composition
WO2023165988A1 (en) 2022-03-01 2023-09-07 Chemo Research, S.L. Chewable oral contraceptive

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3042136A1 (de) * 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
EP0075189B1 (en) * 1981-09-21 1985-08-28 Schering Aktiengesellschaft 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE3414508A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrfach tritiierte steroid-20.17-spirolactone und ihre verwendung als tracersubstanzen
DE3626838A1 (de) * 1986-08-08 1988-02-11 Schering Ag Verfahren zur herstellung von 17(alpha)-pregnan-21,17-carbolactonen
US5106995A (en) * 1989-05-05 1992-04-21 Isp Investments Inc. Production of lactones from diols
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens

Also Published As

Publication number Publication date
DE59712991D1 (de) 2009-02-26
EP0918791A1 (de) 1999-06-02
ES2438941T3 (es) 2014-07-21
KR100473297B1 (ko) 2005-03-07
ATE215557T1 (de) 2002-04-15
SI0918791T1 (en) 2002-12-31
CA2261137A1 (en) 1998-02-19
US6933395B1 (en) 2005-08-23
SI1149841T1 (sl) 2010-02-26
KR20000029939A (ko) 2000-05-25
JP2000516226A (ja) 2000-12-05
CN1158300C (zh) 2004-07-21
EP2168974A2 (de) 2010-03-31
PL331530A1 (en) 1999-07-19
EP1149840B2 (de) 2013-05-15
BG62776B1 (bg) 2000-07-31
EP1149840A3 (de) 2004-12-01
EP0918791B8 (de) 2003-01-08
HU223106B1 (hu) 2004-03-29
HUP9903089A3 (en) 2001-07-30
ATE420098T1 (de) 2009-01-15
UA55423C2 (uk) 2003-04-15
PT918791E (pt) 2002-09-30
BG102976A (en) 1999-08-31
AU729149B2 (en) 2001-01-25
US6121465A (en) 2000-09-19
EP1149841A2 (de) 2001-10-31
IS4965A (is) 1999-01-29
ES2320626T5 (es) 2013-09-05
JP3333524B2 (ja) 2002-10-15
NZ333697A (en) 2000-08-25
CZ297255B6 (cs) 2006-10-11
DK1149840T5 (da) 2013-09-30
WO1998006738A1 (de) 1998-02-19
DK2168974T3 (da) 2014-08-11
EA199900153A1 (ru) 1999-06-24
EP1149841A3 (de) 2004-12-01
ES2320626T3 (es) 2009-05-27
TR199900262T2 (xx) 1999-03-22
DE19633685C1 (de) 1997-10-09
SI1149840T1 (sl) 2009-06-30
IL127963A (en) 2004-06-20
IL127963A0 (en) 1999-11-30
EP2168974A3 (de) 2013-03-06
DK1149841T3 (da) 2010-03-08
SK19499A3 (en) 1999-10-08
CZ47099A3 (cs) 1999-05-12
IS2100B (is) 2006-04-12
DE59713018D1 (de) 2009-12-10
CN1223662A (zh) 1999-07-21
AU4014497A (en) 1998-03-06
ES2335860T3 (es) 2010-04-06
PL187474B1 (pl) 2004-07-30
EA001947B1 (ru) 2001-10-22
EP1149840A2 (de) 2001-10-31
SK283546B6 (sk) 2003-09-11
ES2175451T3 (es) 2002-11-16
ES2438941T1 (es) 2014-01-20
DK0918791T3 (da) 2002-07-15
EP0918791B1 (de) 2002-04-03
EP1149840B1 (de) 2009-01-07
PT2168974E (pt) 2014-08-26
EP2168974B1 (de) 2014-07-02
CA2261137C (en) 2005-03-15
PT1149841E (pt) 2010-01-29
EP1149841B1 (de) 2009-10-28
ATE446966T1 (de) 2009-11-15
DE59706887D1 (de) 2002-05-08
EP0918791B3 (de) 2012-01-18
SI1149840T2 (sl) 2013-08-30
PT1149840E (pt) 2009-03-31
HK1021190A1 (en) 2000-06-02
DK1149840T4 (da) 2013-07-01
ES2175451T7 (es) 2012-11-19
BR9711060A (pt) 1999-08-17

Similar Documents

Publication Publication Date Title
DK1149840T3 (da) Drospirenon (6b, 7b, 15b, 16b-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) med mindre end 0,2% forurening
TR200200460T2 (tr) Yeni fenilpiperazinler
GB2323694B (en) Adaptation in speech to text conversion
GB9706408D0 (en) Speech to text conversion
EP0758025A4 (en) HIGH HARDNESS THERMORESISTANT FERRITIC STEEL NOT SUBJECT TO FRAGILIZATION DUE TO THE DEPOSITION OF INTERMETALLIC COMPOUNDS
AU2003274052A8 (en) Use of cellulose microbeads to make the skin matt
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
CN107642171A (zh) 一种板材连接装置
ID17795A (id) Proses-proses kontinyu untuk konversi 2,5-dihidrofuran menjadi 2,3 dihidrofuran
ATE230996T1 (de) Aus aloe barbadensis isoliertes cinnamoyl-c- glykosid chromon
BR0013709A (pt) Preparação de derivados de dibenzossuberenona através de desidrogenação catalìtica
DE69634738D1 (de) Kompositelektrode für die elektrolyse
Tone Present Situation and Future Plans on Effluent Treatment in Jujo Paper Co., Ltd.
MX9707759A (es) Sistesis de discurso en forma de ondas.
ZA957059B (en) Improved process for the conversion of substituted steroidal 3-halogen-3,5-diene derivatives to substituted steroidal 3,5-diene-3-carboxylic acid derivatives
ES1032841U (es) Taco expansivo de sujeccion.
ITVT940004V0 (it) "nuova capezza maremmana di doannini franco". nuovo modello di utilita' di capezza in corda intrecciata, derivata dalla modifica e perfezionamento del modello tradizionale di capezza in uso in maremma per l 'addestramento dei cavalli.
ZA994944B (en) Catalyst for the hydrogenation of maleic acid to 1,4 butanediol.
ES1027102Y (es) Corrector de fonacion, aplicable en disfemicos.
KR960007310U (ko) 산업폐기물인 비료부산물인 폐석고로 송진함유로 건축공해를 이용하여 건강 증진용 위생석고판